Loomis Sayles & CO L P Novo Nordisk A S Transaction History
Loomis Sayles & CO L P
- $81.4 Billion
- Q3 2025
A detailed history of Loomis Sayles & CO L P transactions in Novo Nordisk A S stock. As of the latest transaction made, Loomis Sayles & CO L P holds 16,165,468 shares of NVO stock, worth $783 Million. This represents 1.1% of its overall portfolio holdings.
Number of Shares
16,165,468
Previous 12,576,031
28.54%
Holding current value
$783 Million
Previous $868 Million
3.34%
% of portfolio
1.1%
Previous 1.12%
Shares
34 transactions
Others Institutions Holding NVO
# of Institutions
1,698Shares Held
303MCall Options Held
27.9MPut Options Held
44.7M-
Capital International Investors Los Angeles, CA17.7MShares$858 Million0.17% of portfolio
-
Franklin Resources Inc San Mateo, CA14MShares$678 Million0.21% of portfolio
-
Bank Of America Corp Charlotte, NC13.4MShares$650 Million0.05% of portfolio
-
Morgan Stanley New York, NY12.4MShares$602 Million0.04% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa10.3MShares$500 Million0.21% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $109B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...